工银国证港股通创新药ETF
(159217)公募股票型指数型
各季度资产配置
| 季报日期 | 净资总值(亿元) | 净资净值(亿元) | 股票 | 债券 | 现金 | 其他 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | |||
| 2026-03-31 | 56.74 | 55.18 | 55.09 | 97.00% | 97.08% | 0.00 | 0.00% | 0.00% | 1.22 | 2.22% | 2.16% | 0.43 | 0.78% | 0.76% |
| 2025-12-31 | 48.61 | 47.51 | 47.36 | 97.36% | 97.41% | 0.00 | 0.00% | 0.00% | 0.48 | 1.00% | 0.98% | 0.78 | 1.64% | 1.61% |
| 2025-09-30 | 54.37 | 54.35 | 54.16 | 99.61% | 99.61% | 0.00 | 0.00% | 0.00% | 0.18 | 0.34% | 0.34% | 0.03 | 0.05% | 0.05% |
| 2025-06-30 | 48.94 | 46.47 | 46.32 | 94.37% | 94.64% | 0.00 | 0.00% | 0.00% | 2.54 | 5.47% | 5.20% | 0.08 | 0.16% | 0.16% |